MATINAS BIOPHARMA HOLDINGS, INC. Cash and Restricted Cash
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Cash and Restricted Cash of $5.99 million as of 2023-03-31, per its 10-Q filed 2023-05-10.
Discontinued › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2023-05-10
- 2023-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.99M.
- 2022-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.08M.
- 2022-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $11.43M.
- 2022-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10.65M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2023-03-31 | $5.99M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $7.08M 10-Q · filed 2023-05-10 | |
| 2022-09-30 | $11.43M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $10.65M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $19.58M 10-Q · filed 2023-05-10 | |
| 2021-12-31 | $21.28M 10-Q · filed 2023-05-10 | |
| 2021-09-30 | $25.17M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $30.69M 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $23.72M 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $12.77M 10-K · filed 2023-03-15 | |
| 2020-09-30 | $7.44M 10-Q · filed 2021-11-08 | $7.44K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $15.39M 10-Q · filed 2021-08-10 | $15.39K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $10.56M 10-Q · filed 2021-05-10 | $10.56K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $22.76M 10-K/A · filed 2022-03-11 | |
| 2019-09-30 | $33.25K 10-Q · filed 2020-11-06 | $33.25M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $37.42K 10-Q · filed 2020-08-10 | $37.42M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $40.00M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $13.01M 10-K · filed 2021-03-29 | $13.01M 10-K · filed 2019-04-01 |
| 2018-09-30 | $7.27M 10-Q · filed 2019-11-13 | $7.27M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $9.54M 10-Q · filed 2019-08-13 | $9.54M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $4.96M 10-Q · filed 2019-05-13 | $4.95M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $8.00M 10-Q · filed 2019-11-13 | $8.00M 10-Q · filed 2018-05-09 |
| 2017-09-30 | $9.69M 10-Q · filed 2018-11-09 | |
| 2017-06-30 | $11.96M 10-Q · filed 2018-08-09 | |
| 2017-03-31 | $16.53M 10-Q · filed 2018-05-09 | |
| 2016-12-31 | $4.80M 10-Q · filed 2018-11-09 | $4.80M 10-Q · filed 2018-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |